Proof Point
Number of personalized medicines invented grew 51% annually between 2008 and 2016, from five to 132
Global Number of Personalized Medicines
2008 – 2016 (number)
Proof Point Findings
- Personalized Medicines – Customized therapy or treatment for disease based on individual’s genetic characteristics
- Steady Growth – Number of personalized medicines rising steadily from just five in 2008 to 132 in 2016, a 51% annual growth
- Drug Approval Rate – One in every four drugs approved by FDA between 2014 and 2016 were personalized medicines
- Increasing Investments – Pharmaceutical companies almost doubled investments in personalized medicine over last five years, predicted to grow by 33% more in next five years
- Diseases Covered – Cancer, Alzheimer's, and arthritis patients expected to benefit most from personalized medicine, as they have highest percentages of drug ineffectivity among patient population
- Key Drivers – Include growing number of therapies available to patients, more investment going to personalized medicines, continuous medical procedure and drug innovation, rising number of patients getting genomes sequenced, improving sequencing technologies, and increasing accessibility of medical information through electronic health records
|
Accelerator |
|
|
Sector |
Healthcare/Health Sciences
|
|
Source |
|
|
Date Last Updated |
June 20, 2017
|
